3P Consulting GmbH is a scientifically led CRO for Real-World Evidence, non-interventional studies, registries and post-authorisation research. We support sponsors and academic partners from study concept to scientific reporting.
Experienced scientific leadership and associated experts with expertise in clinical epidemiology, pharmacoepidemiology, statistics, medical writing and health-services research.
From synopsis and protocol concept to analysis planning, reporting and publication. Focus on non-interventional studies, registries, PASS and publication-driven real-world evidence projects.
Experience across pulmonology, interstitial lung disease, pulmonary hypertension, rheumatology, immunology, cardiovascular medicine, growth hormone treatment and selected rare diseases.
Documented quality-management framework, pharmacovigilance interfaces, EU-GDPR-compliant data-protection processes and project-specific contract and vendor structures.
Therapeutic areas in which our scientific leadership and associated experts bring substantial experience.
Registry-based research, treatment patterns, outcomes, special populations and long-term follow-up concepts.
Real-world evidence on disease progression, survival, treatment use and registry-based scientific analyses.
Non-interventional and PRO-focused studies in inflammatory rheumatic diseases, including pain, disease activity and quality-of-life endpoints.
Long-term observational research, treatment documentation and outcomes in endocrine therapy settings.
Post-authorisation research, safety-oriented documentation and observational evidence generation.
Large observational datasets, outcomes research and clinically oriented evidence generation.
Feasibility-sensitive study concepts, specialised documentation and publication-oriented real-world evidence.
Talk to us about study concept, feasibility, implementation, analysis planning or publication strategy.
contact@3p-consulting.com